← Back to Clinical Trials
Recruiting NCT07158528

NCT07158528 Comparing CAF and TCAF With Soft Tissue Grafting for Treating Multiple Recessions in the Maxilla.

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07158528
Status Recruiting
Phase
Sponsor University Hospital, Ghent
Condition Gingival Recession Generalized Moderate
Study Type INTERVENTIONAL
Enrollment 34 participants
Start Date 2025-08-18
Primary Completion 2037-12-31

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
coronally advanced flap with connective tissue grafttunneled coronally advanced flap with a connective tissue graft

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 34 participants in total. It began in 2025-08-18 with a primary completion date of 2037-12-31.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Multiple techniques can be used for recession coverage. The most common techniques are: tunnel technique (T), coronally advanced flap (CAF) or a combination of both (TCAF). Tunnel and coronally advanced flap are frequently used in clinical practice, whereas the combined technique is a relatively recently developed surgical approach. This randomized controlled trial compares CAF and TCAF to determine which technique provides better root coverage for receding gums at multiple adjacent teeth in the upper jaw. The main question it aims to answer is: \- What is the average root coverage achieved with each technique in the short and long term? This may be clinically relevant because covering gum recession can reduce tooth sensitivity, improve aesthetics and make oral hygiene easier. Researchers will compare the coronally advanced flap (CAF = the gum is detached and repositioned higher) with the tunneled coronally advanced flap (TCAF = the gum is undermined, only partially detached and repositioned higher). In both techniques, a small piece of tissue is removed from the palate, which is used to cover the recession. The purpose of the connective tissue graft under the flap/tunnel is to increase thickness and provide support. Participants will: * Undergo surgery (CAF or TCAF, randomly assigned) to cover recessions * Attend regular check-ups for up to 10 years after surgery * Keep a postoperative journal (recording medication use, pain levels, tooth sensitivity, etc.)

Eligibility Criteria

Inclusion Criteria: * At least 18 years of age * Good oral hygiene * Presence of multiple gingival recessions in the maxilla * Good general health Exclusion Criteria: * Smoker * Pregnant women (assessed at each visit; if the patient becomes pregnant during follow-up, radiographs will not be taken)

Contact & Investigator

Central Contact

Véronique Prof. Dr. Christiaens

✉ vchristi.christiaens@ugent.be

📞 +32 332 40 17

Frequently Asked Questions

Who can join the NCT07158528 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Gingival Recession Generalized Moderate. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07158528 currently recruiting?

Yes, NCT07158528 is actively recruiting participants. Contact the research team at vchristi.christiaens@ugent.be for enrollment information.

Where is the NCT07158528 trial being conducted?

This trial is being conducted at Ghent, Belgium.

Who is sponsoring the NCT07158528 clinical trial?

NCT07158528 is sponsored by University Hospital, Ghent. The trial plans to enroll 34 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology